Thyrocare Technologies Limited — Updates, 23-07-2026: Press Release
23-07-2026 | 04:07 pm
23-07-2026 | 04:07 pm
Thyrocare reported strong Q1FY27 results: Revenue surged 24% YoY to ₹240.02 Cr, EBITDA 34% to ₹77.27 Cr, and PAT 34% to ₹51.33 Cr. It processed 55.2 million tests, up 28%. The company also expanded into Specialty Diagnostics.
No comments yet. Be the first to comment!
